Quorum sensing regulates a host of bacterial behaviors including virulence, biofilm formation, toxin and antibiotic production, luminescence, and motility. Different species of bacteria use a furanosyl derivative as the type 2 autoinducer (AI-2) for interspecies communication. AI-2 is biosynthesized from S-adenosylmethionine via three enzymatic steps. The long-term objectives of this project are (1) to determine the catalytic mechanisms of enzymes involved in bacterial quorum sensing, and (2) to develop specific inhibitors against the synthesis and/or detection of AI-2 as novel antibacterial agents. During this grant period, the project will focus on the catalytic mechanism and inhibition of S-ribosylhomocysteinase (LuxS), which catalyzes the last step of AI-2 biosynthesis. LuxS is a new type of non-heme Fe2+containing enzyme and has a novel catalytic mechanism.
In Specific Aim 1, putative catalytic intermediates and substrate analogs will be chemically synthesized and kinetically characterized to demonstrate their involvement in the catalytic pathway. The structures of LuxS in complex with these intermediates and analogs will be determined by X-ray crystallography.
Specific Aim 2 is to determine the role of the metal ion in catalysis by electronic absorption and magnetic circular dichroism spectroscopies.
Specific Aim 3 is to determine the function of conserved active-site residues in catalysis by site-directed mutagenesis and kinetic and spectroscopic characterization of the mutants.
In Specific Aim 4, mechanism-based and metal-chelating inhibitors will be designed and synthesized. The inhibitors will be tested for inhibition of LuxS and antibacterial activity. The mechanism-based inhibitors will also serve as mechanistic probes for studying the LuxS mechanism. Finally, Specific Aim 5 is to purify and identify additional receptor(s) for AI-2.

National Institute of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Research Project (R01)
Project #
Application #
Study Section
Macromolecular Structure and Function A Study Section (MSFA)
Program Officer
Korpela, Jukka K
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Ohio State University
Schools of Medicine
United States
Zip Code
Wu, Xianghong; Wang, Lisheng; Han, Yaohua et al. (2011) Creating diverse target-binding surfaces on FKBP12: synthesis and evaluation of a rapamycin analogue library. ACS Comb Sci 13:486-95
Malladi, Venkata L A; Sobczak, Adam J; Meyer, Tiffany M et al. (2011) Inhibition of LuxS by S-ribosylhomocysteine analogues containing a [4-aza]ribose ring. Bioorg Med Chem 19:5507-19
Wnuk, Stanislaw F; Robert, Jenay; Sobczak, Adam J et al. (2009) Inhibition of S-ribosylhomocysteinase (LuxS) by substrate analogues modified at the ribosyl C-3 position. Bioorg Med Chem 17:6699-706
Gopishetty, Bhaskar; Zhu, Jinge; Rajan, Rakhi et al. (2009) Probing the catalytic mechanism of S-ribosylhomocysteinase (LuxS) with catalytic intermediates and substrate analogues. J Am Chem Soc 131:1243-50
Shen, Gang; Zhu, Jinge; Simpson, Anthony M et al. (2008) Design and synthesis of macrocyclic peptidyl hydroxamates as peptide deformylase inhibitors. Bioorg Med Chem Lett 18:3060-3
Zhu, Jinge; Pei, Dehua (2008) A LuxP-based fluorescent sensor for bacterial autoinducer II. ACS Chem Biol 3:110-9
Wnuk, Stanislaw F; Lalama, Jennifer; Garmendia, Craig A et al. (2008) S-Ribosylhomocysteine analogues with the carbon-5 and sulfur atoms replaced by a vinyl or (fluoro)vinyl unit. Bioorg Med Chem 16:5090-102
Nguyen, Kiet T; Wu, Jen-Chieh; Boylan, Julie A et al. (2007) Zinc is the metal cofactor of Borrelia burgdorferi peptide deformylase. Arch Biochem Biophys 468:217-25
Shen, Gang; Rajan, Rakhi; Zhu, Jinge et al. (2006) Design and synthesis of substrate and intermediate analogue inhibitors of S-ribosylhomocysteinase. J Med Chem 49:3003-11
Zhu, Jinge; Knottenbelt, Sushilla; Kirk, Martin L et al. (2006) Catalytic mechanism of S-ribosylhomocysteinase: ionization state of active-site residues. Biochemistry 45:12195-203